Panel moderator – Deirdre C. Kelleher, M.D.
Decommissioning of Nitrous Oxide: Understanding the How and Why of the 2024 ASA Statement – Deirdre C. Kelleher, M.D.
Hypoxemia Is Not Always the Same: What the FDA Guidelines for Pulse Oximetry Tell Us About Our Monitors and Equity – Olubunmi Okunlola, M.D.
Needles Meet Blood Thinners: The New ASRA Anticoagulation Guidelines – Sandra L. Kopp, M.D.
The Physiologically Difficult Airway: Guidance from SOCCA – Craig S. Jabaley, M.D.

After completion of this session, the participant will be able to:

• Create anesthetic plans to optimize the differential environmental and cost impact of piped versus point-of-care nitrous oxide delivery.
• Appraise effect of skin tone when interpreting pulse oximetry readings.
• Execute a stepwise approach for the management of an unanticipated physiologically difficult airway.